E J A Gerritsen
Research Subjects
E J A Gerritsen has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
A Cant
Department of Pediatrics, General Hospital, Newcastle, UK
1 shared publicationA Fasth
Department of Pediatrics, Queen Silvia's Children's Hospital, Göteborg, Sweden
1 shared publicationA Fischer
Hôpital Necker Enfants Malades, Paris, France
1 shared publication- Aloysius C. M. Kroes
Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands
1 shared publication - Colin Graham Steward
Bone Marrow Transplant Unit, Royal Hospital for Children, Bristol, United Kingdom
1 shared publication D Uckan
Hacettepe Children's Hospital, Ankara, Turkey
1 shared publication
Latest Publications
- Open Access
- 16 September 2003
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 32 (7) , 657-663
Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report
A retrospective analysis was made of 122 children who had received an allogeneic haematopoietic stem cell transplantation (HSCT) for autosomal recessive osteopetrosis between 1980 and 2001. The actuarial probabilities of 5 years disease free survival were 73% for recipients of a genotype HLA-identical HSCT (n=40), 43% for recipients of a phenotype HLA-identical or one HLA-antigen mismatch graft from a related donor (n=21), 40% for recipients of a graft from a matched unrelated donor (n=20) and 24% for patients who received a graft from an HLA-haplotype-mismatch related donor (n=41). In the latter group, a trend towards improvement was achieved at the end of the study period (17% before 1994, 45% after 1994, P=0.11). Causes of death after HSCT were graft failure and early transplant-related complications. Severe visual impairment was present in 42% of the children before HSCT. Conservation of vision was better in children transplanted before the age of 3 months. Final height was related to height at the time of HSCT and better preserved in children transplanted early. Most children attended regular school or education for the visually handicapped. At present, HSCT is the only curative treatment for autosomal recessive osteopetrosis and should be offered as early as possible.
- 16 September 2003
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 32 (7) , 657-663
Open AccessLong-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report
A retrospective analysis was made of 122 children who had received an allogeneic haematopoietic stem cell transplantation (HSCT) for autosomal recessive osteopetrosis between 1980 and 2001. The actuarial probabilities of 5 years disease free survival were 73% for recipients of a genotype HLA-identical HSCT (n=40), 43% for recipients of a phenotype HLA-identical or one HLA-antigen mismatch graft from a related donor (n=21), 40% for recipients of a graft from a matched unrelated donor (n=20) and 24% for patients who received a graft from an HLA-haplotype-mismatch related donor (n=41). In the latter group, a trend towards improvement was achieved at the end of the study period (17% before 1994, 45% after 1994, P=0.11). Causes of death after HSCT were graft failure and early transplant-related complications. Severe visual impairment was present in 42% of the children before HSCT. Conservation of vision was better in children transplanted before the age of 3 months. Final height was related to height at the time of HSCT and better preserved in children transplanted early. Most children attended regular school or education for the visually handicapped. At present, HSCT is the only curative treatment for autosomal recessive osteopetrosis and should be offered as early as possible.
- 1 May 1997
- Published by Springer Nature in Pediatric Research
- Vol. 41 (5) , 730
SEVERE COMPLICATIONS DUE TO REACTIVATION OF DNA-VIRUSES POST-BMT: RELATIONSHIP WITH IMMUNE STATUS OF THE HOST AND PERSPECTIVES FOR THERAPY 7
- 1 May 1997
- Published by Springer Nature in Pediatric Research
- Vol. 41 (5) , 730
SEVERE COMPLICATIONS DUE TO REACTIVATION OF DNA-VIRUSES POST-BMT: RELATIONSHIP WITH IMMUNE STATUS OF THE HOST AND PERSPECTIVES FOR THERAPY 7